{"nct_id":"NCT03574649","title":"QUILT-2.024: Phase 2 Neoadjuvant, Consolidation, and Adjuvant Combination NANT Immunotherapy Versus Standard of Care in Subjects With Resectable Non-small Cell Lung Cancer","status":"WITHDRAWN","status_verified_date":"2018-06","start_date":"2018-06","start_date_type":"ESTIMATED","primary_completion_date":"2018-08","primary_completion_date_type":"ESTIMATED","completion_date":"2018-08-22","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["IBRX"]}